Bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases
Honing Biosciences has raised €2.0M across 1 funding round from 1 investor, most recently a Pre-Seed round in Jul 2020. Based in Paris, France; founded 1909; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-07 | Pre-Seed | €2.0M |
| Elaia |
| View deal → |
